New York, United States
Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease.
23
Total Investments
14
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Financial Services, Health Care
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Adjuvant Capital
Recent Investments (23)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Mar 2025 | |
| Series C | •••••• | Nov 2023 | |
| Series E | •••••• | Apr 2023 | |
| Series B | •••••• | Feb 2023 | |
| Series B | •••••• | Jan 2023 | |
•••• ••••
|
Series C | •••••• | Dec 2022 |
|
•••• ••••
|
Series C | •••••• | Dec 2022 |
|
•••• ••••
|
Series A | •••••• | Nov 2022 |
|
•••• ••••
|
Series D | •••••• | Oct 2022 |
|
•••• ••••
|
Convertible Note | •••••• | Oct 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
